
Maris R. Kessel
Examiner (ID: 14775, Phone: (571)270-7698 , Office: P/1759 )
| Most Active Art Unit | 1759 |
| Art Unit(s) | 1795, 1759, 1758, 1699 |
| Total Applications | 485 |
| Issued Applications | 239 |
| Pending Applications | 11 |
| Abandoned Applications | 232 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18784710
[patent_doc_number] => 20230372317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => A LIQUID INJECTABLE COMPOSITION OF DONEPEZIL
[patent_app_type] => utility
[patent_app_number] => 18/247943
[patent_app_country] => US
[patent_app_date] => 2021-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247943
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247943 | A LIQUID INJECTABLE COMPOSITION OF DONEPEZIL | Oct 24, 2021 | Pending |
Array
(
[id] => 17546596
[patent_doc_number] => 20220117937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => USE OF SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION IN BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 17/502975
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502975
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502975 | Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms | Oct 14, 2021 | Issued |
Array
(
[id] => 18815970
[patent_doc_number] => 20230390309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => TETRACYCLINE DERIVATIVES FOR TREATING NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/031632
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031632
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031632 | TETRACYCLINE DERIVATIVES FOR TREATING NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES | Oct 13, 2021 | Pending |
Array
(
[id] => 18852679
[patent_doc_number] => 11850231
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-26
[patent_title] => Trytophan metabolic stimulation compositions
[patent_app_type] => utility
[patent_app_number] => 17/500070
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3618
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500070
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500070 | Trytophan metabolic stimulation compositions | Oct 12, 2021 | Issued |
Array
(
[id] => 18817447
[patent_doc_number] => 20230391787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => ORGANIC MOLECULE LIGHT EMITTERS
[patent_app_type] => utility
[patent_app_number] => 18/030634
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 582
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030634
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030634 | ORGANIC MOLECULE LIGHT EMITTERS | Oct 7, 2021 | Pending |
Array
(
[id] => 17533611
[patent_doc_number] => 20220112220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => FORMULATION OF A PAN-JAK INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/450205
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450205
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/450205 | Formulation of a pan-JAK inhibitor | Oct 6, 2021 | Issued |
Array
(
[id] => 18786041
[patent_doc_number] => 20230373997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/030302
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -93
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030302
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030302 | IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF | Oct 6, 2021 | Pending |
Array
(
[id] => 18808544
[patent_doc_number] => 20230382878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => A METHOD FOR INCREASING PROPYLENE OXIDE OUTPUT OF AN INTEGRATED PROCESS FOR MAKING PROPYLENE OXIDE AND PROPYLENE GLYCOL
[patent_app_type] => utility
[patent_app_number] => 18/249584
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249584
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/249584 | A METHOD FOR INCREASING PROPYLENE OXIDE OUTPUT OF AN INTEGRATED PROCESS FOR MAKING PROPYLENE OXIDE AND PROPYLENE GLYCOL | Oct 6, 2021 | Pending |
Array
(
[id] => 17851829
[patent_doc_number] => 20220281871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/492282
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492282 | Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK Inhibitors | Sep 30, 2021 | Abandoned |
Array
(
[id] => 17356722
[patent_doc_number] => 20220017518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Histone Deacetylase Inhibitors and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/487279
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17487279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/487279 | Histone Deacetylase Inhibitors and Methods of Use Thereof | Sep 27, 2021 | Abandoned |
Array
(
[id] => 17480480
[patent_doc_number] => 20220087984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => USE OF TACROLIMUS IN PREPARATION OF MEDICAMENT FOR INITIATING TISSUE REGENERATION FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/479869
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479869 | Use of tacrolimus in preparation of medicament for initiating tissue regeneration function | Sep 19, 2021 | Issued |
Array
(
[id] => 18753919
[patent_doc_number] => 20230357261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => ARYL HYDROCARBON RECEPTOR LIGANDS AND THEIR ANALOGUES FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/025797
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025797
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025797 | ARYL HYDROCARBON RECEPTOR LIGANDS AND THEIR ANALOGUES FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISORDERS | Sep 16, 2021 | Pending |
Array
(
[id] => 19201397
[patent_doc_number] => 20240173296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => PHARMACEUTICAL COMPOSITION OF (S)-KETOROLAC AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/776428
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776428 | PHARMACEUTICAL COMPOSITION OF (S)-KETOROLAC AND PREPARATION METHOD THEREFOR | Sep 16, 2021 | Pending |
Array
(
[id] => 18768637
[patent_doc_number] => 20230363391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => Biocidal Composition and Method
[patent_app_type] => utility
[patent_app_number] => 18/026204
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026204
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026204 | Biocidal Composition and Method | Sep 13, 2021 | Pending |
Array
(
[id] => 18287599
[patent_doc_number] => 20230103071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD FOR PURIFICATION OF TERPENOID AMINO ALCOHOL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/467974
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/467974 | Method for purification of terpenoid amino alcohol derivatives | Sep 6, 2021 | Issued |
Array
(
[id] => 19871328
[patent_doc_number] => 12264172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Phosphonate products and methods
[patent_app_type] => utility
[patent_app_number] => 18/043987
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 8
[patent_no_of_words] => 28507
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043987
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043987 | Phosphonate products and methods | Sep 1, 2021 | Issued |
Array
(
[id] => 18726018
[patent_doc_number] => 20230340270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => CYANINE COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT
[patent_app_type] => utility
[patent_app_number] => 18/026687
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026687
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026687 | CYANINE COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | Aug 31, 2021 | Pending |
Array
(
[id] => 17299393
[patent_doc_number] => 20210395232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => CO-CRYSTAL FORMS OF SELINEXOR
[patent_app_type] => utility
[patent_app_number] => 17/446664
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17446664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/446664 | CO-CRYSTAL FORMS OF SELINEXOR | Aug 31, 2021 | Pending |
Array
(
[id] => 20329680
[patent_doc_number] => 12459945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents
[patent_app_type] => utility
[patent_app_number] => 17/459960
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 12
[patent_no_of_words] => 26731
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/459960 | Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents | Aug 26, 2021 | Issued |
Array
(
[id] => 18496442
[patent_doc_number] => 20230219015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => EXTRACTION METHOD AND MIXTURE OF SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 18/022869
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022869
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022869 | EXTRACTION METHOD AND MIXTURE OF SUBSTANCES | Aug 25, 2021 | Pending |